Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Proceedings. Mathematical, Physical, and Engineering Sciences|April 18, 2017
A restatement of the natural science evidence concerning catchment-based 'natural' flood management in the UKSimon J Dadson, Jim W Hall, Anna Murgatroyd, et al.Experimental Parasitology|June 23, 2010
Leishmania species: detection and identification by nested PCR assay from skin samples of rodent reservoirsAmir Ahmad Akhavan, Hossein Mirhendi, Ali Khamesipour, et al.Molecular Therapy. Methods & Clinical Development|March 28, 2017
INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site DistributionsCharles C Berry, Christopher Nobles, Emmanuelle Six, et al.Molecular Therapy. Methods & Clinical Development|March 28, 2017
INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular GenomesEric Sherman, Christopher Nobles, Charles C Berry, et al.The Journal of Pharmacology and Experimental Therapeutics|April 27, 2023
Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory DrugsCarsten Skarke, Ronan Lordan, Kayla Barekat, et al.Journal of Virology|March 21, 2024
Modeling Heartland virus disease in mice and therapeutic intervention with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Cigdem Alkan, et al.Immunity|December 9, 2020
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody GenerationKatlyn Lederer, Diana Castaño, Daniela Gómez Atria, et al.Cell Reports|October 19, 2022
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinationsElizabeth M Anderson, Shuk Hang Li, Moses Awofolaju, et al.Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Kalpana Parvathaneni, Mark M Painter, et al.Journal of the Pediatric Infectious Diseases Society|December 2, 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.Pageof 9